Serbia Hearing Aid Retailers Market: as Neuroth advances construction of its Zemun Polje earmold production facility toward a planned November 2026 production start, and Amplifon's agreement to acquire GN Group's global hearing business reshapes the international retail landscape those same Serbian retailers ultimately draw brands from, local production capability and global retail consolidation are converging on the same Southeast European market at once.

The Serbia hearing aid retailers market size was USD 104 Million in 2025 and is expected to register a revenue CAGR of 7.0% during the forecast period.Market revenue growth is driven by factors such as accelerating strategic commitment from Austrian retail chain Neuroth including its first hearing aid production facility outside Austria, an aging Serbian population with growing awareness of hearing health, and increasing uptake of digital and receiver-in-the-ear devices.The first driving factor is accelerating strategic commitment from international hearing aid retailers, most notably Neuroth's Belgrade production facility investment, signalling Serbia's growing significance as one of Southeast Europe's most commercially significant hearing aid retail territories.The second driving factor is an aging Serbian population with growing awareness of hearing health, sustaining structural demand growth for hearing aids among the geriatric population segment that continues to represent the largest patient base.The third driving factor is increasing uptake of digital and receiver-in-the-ear devices, as consumer preference shifts toward discreet, technologically advanced hearing aid formats offering Bluetooth streaming and rechargeable battery capability.These are some of the key factors driving revenue growth of the market.

A second layer of demand comes from the way a hearing aid retailer's local production investment widens its addressable Southeast European distribution reach every time that facility's output capacity is confirmed, converting a single manufacturing investment into a regional supply chain advantage that benefits the retailer's entire Balkan clinic network, not just its Serbian locations alone.Once a retailer establishes local earmold or component production capacity within Serbia, every hearing centre across its wider Southeast European network, spanning Slovenia, Croatia, Serbia, and Bosnia-Herzegovina, gains a shorter, more resilient supply chain for custom-fitted components, so the Belgrade investment's value compounds across the retailer's regional footprint rather than benefiting the Serbian market in isolation.As a result, demand and revenue share are concentrating around retailers with the deepest combined regional clinic network and local production capability, and the forecast tilts toward these production-backed regional retailers rather than distributors reliant entirely on imported finished product.For instance, as of March 2026, Neuroth Production SEE had submitted a formal request for an environmental impact assessment for its earmold production facility at Zemun Polje in Belgrade, with construction planned to begin in February 2026, completion expected by October 2026, and production anticipated to start in November 2026, targeting initial capacity of approximately 11,000 earmolds annually with room to scale toward 35,000 units as market demand grows.These are some of the key factors driving revenue growth of the market.

Because Serbia's public health insurance reimbursement for hearing aids remains limited relative to Western European national health systems, this creates an affordability barrier that concentrates premium digital and RITE device adoption among higher-income, urban Serbian consumers.

Price sensitivity among lower-income rural populations is a second constraint, as consumers outside Belgrade and Vojvodina's more affluent urban centres continue to favour lower-cost analog and basic digital hearing aid options over premium technology tiers.

Specialist audiologist and hearing care professional availability outside major urban centres is a third constraint, as Serbia's most developed hearing centre and specialist clinic infrastructure remains concentrated in Belgrade and Novi Sad, limiting convenient access to professional fitting and follow-up care in more rural regions.

These factors substantially limit Serbia hearing aid retailers market growth over the forecast period.

The clearest driver of demand is the transition from a strategic investment announcement to confirmed, dated construction progress, giving the Serbian market a genuine local manufacturing anchor rather than remaining dependent entirely on Austrian and other Western European import supply. A regional retail chain only captures the full commercial benefit of a local production facility if construction proceeds on a confirmed, credible timeline, and as of March 2026, Neuroth Production SEE had submitted its formal environmental impact assessment request for the Zemun Polje facility, with construction planned to begin in February 2026 and production anticipated to start in November 2026. The facility's initial planned capacity of approximately 11,000 custom-made acrylic and silicone earmolds annually, with room to scale toward a maximum capacity of 35,000 units as market demand grows, gives Neuroth SEE's entire Southeast European clinic network, spanning Slovenia, Croatia, Serbia, and Bosnia-Herzegovina, a regional production source for earmolds worn behind the ear or with an in-ear speaker. Neuroth's Regional Director for Southeast Europe confirmed during the facility's foundation stone-laying ceremony that Serbia serves as merely the starting point, not the sole beneficiary, of the region's expanded production capability. The effect on the market is that Neuroth's competitive position in Serbia is increasingly reinforced by manufacturing proximity and regional supply chain resilience, not solely by its established 14-plus hearing centre retail footprint. These are some of the key factors driving revenue growth of the market.

The second driver, an indirect but structurally significant one, is the way global hearing aid industry consolidation reshapes the brand and distribution relationships that Serbian retailers depend on for product sourcing. A Serbian hearing aid retailer's product portfolio depends on stable brand and distribution relationships with international manufacturers, and Amplifon's agreement to acquire GN Group's entire hearing business, comprising the ReSound and Beltone brands along with all hearing product intellectual property, research and development, and manufacturing operations, for DKK 17 Billion creates the largest global integrated hearing technology and retail company to date. GN Group's Hearing business generated DKK 7,214 Million in 2025 revenue, and the transaction represents the complete opposite of the trend among GN's competitors, who have historically acquired retail operators rather than a technology manufacturer being acquired by the world's largest hearing aid retailer. For Serbian retailers currently distributing Phonak, WIDEX, or other international brands, this scale of consolidation among global manufacturers signals that brand ownership, distribution terms, and product roadmap priorities across the broader hearing aid industry are actively being renegotiated at the corporate level well beyond Serbia's borders. The effect on the market is that Serbian retailers should expect continued upstream consolidation among the international manufacturers whose products they distribute, even as local competitive dynamics remain shaped primarily by Neuroth's production investment and established clinic network. These are some of the key factors driving revenue growth of the market.

“Neuroth's Zemun Polje facility, targeting a November 2026 production start with initial capacity of approximately 11,000 earmolds annually scaling toward 35,000, gives the company's entire Southeast European clinic network, not Serbia alone, a genuine regional manufacturing anchor.”

However, the Serbia hearing aid retailers market faces adoption constraints from limited public health insurance reimbursement, price sensitivity among lower-income rural populations, and specialist audiologist availability outside major urban centres.

Because Serbia's public health insurance reimbursement for hearing aids remains limited relative to Western European national health systems, this creates an affordability barrier that concentrates premium digital and RITE device adoption among higher-income, urban Serbian consumers, particularly in Belgrade.

Price sensitivity among lower-income rural populations compounds this, as consumers outside Belgrade and Vojvodina's more affluent urban centres continue to favour lower-cost analog and basic digital hearing aid options over the premium technology tiers driving overall market revenue growth.

Specialist audiologist and hearing care professional availability outside major urban centres is the third constraint, as Serbia's most developed hearing centre and specialist clinic infrastructure remains concentrated in Belgrade and Novi Sad, limiting convenient access to professional fitting and follow-up care for patients in Southern and Eastern Serbia and other more rural regions.

These factors substantially limit Serbia hearing aid retailers market growth over the forecast period.

Based on patient age, the Serbia hearing aid retailers market is segmented into geriatric patients aged 65 and above, adults aged 18 to 64, and pediatric patients aged 0 to 17. The geriatric segment accounts for the largest revenue share at approximately 58% of 2025 market revenue, driven by the high prevalence of age-related sensorineural hearing loss among Serbia's elderly population. The adult segment accounts for approximately 35% of market revenue and is expected to register a growing CAGR, driven by increasing noise-induced hearing loss among working-age Serbians and rising awareness of early hearing aid intervention benefits.

Belgrade Region accounted for the largest revenue share in the Serbia hearing aid retailers market in 2025.

The Belgrade Region accounted for the largest revenue share at approximately 38% of the Serbian hearing aid retailers market in 2025, driven by its dense population of approximately 1.7 million residents and its position as the country's economic and healthcare centre with the most developed specialist audiology infrastructure. Neuroth's 14-plus hearing centre presence in Serbia includes multiple Belgrade metropolitan locations, and the Zemun Polje production facility, targeting a November 2026 production start, will further strengthen Neuroth's market position in the city that serves as Serbia's primary hearing aid retail hub. Belgrade's highest consumer purchasing power in Serbia continues to support premium digital hearing aid adoption above the national average.

Vojvodina, Serbia's northern autonomous province bordering Hungary, Romania, and Croatia with its capital in Novi Sad, represents the second-largest regional hearing aid retail market at approximately 22% of 2025 national revenue. This reflects Novi Sad's position as Serbia's second city with developed urban healthcare infrastructure, higher-than-average regional consumer income levels supported by Vojvodina's agricultural and manufacturing economy, and cross-border proximity to Hungary and Croatia where hearing aid awareness and adoption rates are higher. Iran-US sanctions and Red Sea shipping disruptions have not directly, materially affected Serbia's hearing aid import logistics given the dominant Danish and Austrian import sourcing, but elevated global component logistics costs have contributed to average selling price increases across the Serbian retail market.

Šumadija and Western Serbia, Southern and Eastern Serbia, and the Kosovo and Metohija Region collectively represent the remaining share of the national market, with hearing aid retail access concentrated at regional urban centres and increasingly served by Neuroth's continued Southeast European expansion, including the company's 14th Serbian hearing centre opened in Kraljevo, the first Neuroth location in the Zlatibor region.